Boxing Day: 3 TSX Stocks That Are on Sale

A gloomy Boxing Day in 2020 should inspire Canadians to hunt undervalued TSX stocks like Canadian Western Bank (TSX:CWB) and others today.

| More on:
edit Sale sign, value, discount

Image source: Getty Images

Boxing Day has arrived across Canada. This may be the quietest day for foot traffic in retailers and malls since post-Christmas Boxing Day sales were conceptualized. Retailers are a risky bet right now, but Canadian investors should not turn away from the red-hot market entirely. Today, I want to look at three TSX stocks that offer attractive value as we look ahead to the new year. Let’s jump in.

TSX stock on sale: A housing dividend star to stash right now

Genworth MI Canada (TSX:MIC) is the first Boxing Day TSX stock on sale that I want to zero in on today. This company is the largest private residential mortgage insurer in Canada. The pandemic has wreaked havoc on several sectors. In the spring, some analysts predicted that housing would take a major hit. Those who stuck with Canada’s resilient housing sector have been rewarded. Sales and prices erupted in the spring and summer.

Shares of Genworth have climbed 29% over the past three months as of close on December 23. The stock is still down 11% in 2020. Net income rose 12% year over year to $124 million in the third quarter. Moreover, transactional premiums surged from the prior year on the back of a resurgence for the domestic real estate market.

This TSX stock last possessed an attractive price-to-earnings (P/E) ratio of nine and a price-to-book (P/B) value of one. Genworth offers a quarterly dividend of $0.54 per share, representing a solid 4.9% yield. Value investors can’t ignore Genworth on Boxing Day.

Why investors should be targeting healthcare stocks before 2021

This week, I’d recommended investors follow Warren Buffett’s lead and snag promising healthcare stocks. VieMed Healthcare (TSX:VMD) is a top TSX stock in the healthcare space. The company provides in-home durable medical equipment and healthcare solutions to patients across the United States. Its shares have increased 26% in 2020. Shares have dropped 14% month over month.

VieMed has lent its hand to the public and private sector during the pandemic. It possesses expertise in treating respiratory illnesses and is a well-known ventilator supplier. This meant it had specialized services to offer in this crisis. In Q3 2020, VieMed pointed out that the pandemic had contributed between $5 million and $6 million to its total revenue.

Best of all, this TSX stock has a favourable P/E ratio of 11. VieMed looked like a promising add before the pandemic. It is a must-add in this environment.

One more TSX stock with a fantastic history to add

Financials struggled early in 2020, as uncertainty shook the market. Fortunately, Canadian bank stocks have managed to recoup nearly all losses from the early part of the year. Canadian Western Bank (TSX:CWB) is a top regional bank. It does not offer the size or reach of its Big Six counterparts. However, what it lacks in those areas it makes up for in its dividend history.

This TSX stock has climbed 10% over the past three months. In Q4 2020, the bank saw total revenue rise 7% year over year to $237 million. Loans and bank-raised deposits increased 2% and 4%, respectively, over the previous quarter. Canadian Western Bank possesses a good P/E ratio of 10 and a P/B value of 0.9.

In Q4 2020, Canadian Western Bank announced a quarterly dividend of $0.29 per share. That represents a 4% yield. It has delivered dividend growth for 28 consecutive years. Forget the Big Six, Canadian Western is a TSX stock worth holding for the long haul.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Viemed Healthcare Inc.

More on Investing

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Woman has an idea
Investing

3 No-Brainer Stocks to Buy With $200 Right Now

These three stocks are no-brainer buys, given their solid underlying businesses and healthy growth prospects.

Read more »

Investing

2 Stocks I’m Loading Up on in 2024

Alimentation Couche-Tard (TSX:ATD) and another stock that are getting too cheap after their latest corrections.

Read more »

grow money, wealth build
Dividend Stocks

1 Top Dividend Stock That Can Handle Any Kind of Market (Even Corrections)

While most dividend aristocrats can maintain their payouts during weak markets, very few can maintain a healthy valuation or bounce…

Read more »

Red siren flashing
Dividend Stocks

Income Alert: These Stocks Just Raised Their Dividends

Three established dividend-payers from different sectors are compelling investment opportunities for income-focused investors.

Read more »

online shopping
Tech Stocks

1 Hidden Catalyst That Could Ignite Shopify Stock

Here's why Shopify (TSX:SHOP) ought to remain a top growth stock investors continue to focus on for the long haul.

Read more »

Oil pumps against sunset
Energy Stocks

Is it Too Late to Buy Enbridge Stock?

Besides its juicy and sustainable dividends, Enbridge’s improving long-term growth prospects make it a reliable stock to hold for the…

Read more »

Man considering whether to sell or buy
Tech Stocks

WELL Stock: Buy, Sell, or Hold?

WELL stock has a lot of upside as the company is likely to continue to grow, posting positive earnings in…

Read more »